SCHEMBL29746740

SCHEMBL29746740

CNc1cc(Nc2cccn(-c3ccc(OC)nn3)c2=O)nc2c(C(=O)NCC(F)(F)F)cnn12

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22342888 1.00 TYK2 (0.67) TYK2
SCHEMBL29746674 0.93 TYK2 (0.67) TYK2
SCHEMBL22342869 0.93 TYK2 (0.67) TYK2
SCHEMBL22342890 0.92 TYK2 (0.69) TYK2
SCHEMBL22342872 0.91 TYK2 (0.65) TYK2
SCHEMBL29746763 0.91 TYK2 (0.65) TYK2
SCHEMBL22343293 0.86 TYK2 (0.85) TYK2
SCHEMBL22343299 0.85 TYK2 (0.86) TYK2
SCHEMBL22342912 0.85 TYK2 (0.75) TYK2
SCHEMBL22343300 0.83 TYK2 (0.64) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2022-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback